Understanding and therapeutically guiding motor development and motor control is a complex and challenging topic for professionals and caregivers within the field of neuropaediatric rehabilitation. [1] [2] [3] Motor control is a primary determinant for physiological or 'normal'movement. 4 When measuring motor control, the following question must be considered: 'how are motor units selected, activated and deactivated?' 5 In children with upper motor neuron (UMN) lesions, the muscle control mechanism of selected activation and deactivation is often disturbed and causes non-physiological movements (patterns). 3, 6 Clinically, this is known as a loss of selective voluntary motor control (SVMC). [6] [7] [8] Selective motor control is defined as the ability 'to isolate the activation of muscles in a selected pattern in response to demands of a voluntary movement or posture'. 8 The term 'voluntary' within SVMC emphasizes the deliberate performance of selected muscle activation during functional tasks. 7 Pathophysiologically, a loss of SVMC is related to impaired descending corticospinal input, which results in disturbed control of spinal networks. 6, 8 Complex muscle activation patterns of agonist, synergist, and antagonist are disturbed. 8, 9 This allows the appearance of flexor and/or extensor mass movement patterns (i.e. synergies), which often limits the patient's control of movement. 7 For patients with a complete loss of SVMC, strength and functional training is only possible within synergies, potentially accompanied by co-movements and mirror movements of other muscle groups. This could limit the patient's ability to increase or maintain strength of a specific weak muscle (group). [6] [7] [8] [9] Therefore, in the long term, impaired SVMC can result in a vicious circle of limited motor performance during daily life activities, secondary deformities, and pain. 6, 7, 10 Studies investigating the impact of different motor impairments in children with cerebral palsy (CP) have shown that a loss of SVMC limits motor performance more than other routinely measured impairments such as spasticity and/or contractures. [10] [11] [12] [13] Recently, selective motor control has been listed in the International Classification of Functioning, Disability and Health: Children & Youth Version (ICF) core sets for children and youth with CP (b7600), 14 underscoring its clinical importance within this patient group. Furthermore, for many ambulatory children with UMN lesions and their caregivers, learning to walk/move 'normally' (i.e. within a physiological pattern or without synergistic mass patterns) is a commonly mentioned rehabilitation goal. 15, 16 Although achieving a 'normalized' walking pattern training of multiple body functions (e.g. balance, strength) is necessary, SVMC plays a major role in performing qualitative good walking movements. 13 Despite the social and pathophysiological importance of SVMC, evidence about its trainability in children with CP is relatively limited. [17] [18] [19] [20] One possible reason for the small number of intervention studies to improve SVMC might be related to the challenges of measuring motor control. 7 In contrast to measuring motor function, which is readily done in numbers by asking 'how fast' or 'how often' a movement is performed, measuring motor control is more difficult because it looks at 'how' the movement is controlled and executed.
1,2,7 Nevertheless, for being able to assess rehabilitation-induced (medical/therapeutical) changes of SVMC, the availability of valid, reliable, and responsive SVMC outcome measures are fundamental.
There is currently no systematic review of the psychometric properties of SVMC measures for the lower extremity for children with UMN lesions; the purpose of this study was to address this gap. By focusing on the lower extremity, we aimed to extend the observations from a recent systematic review, 21 which investigated psychometric properties of tests scoring either compensatory or physiological movements of the upper extremity in children with UMN lesions. Providing an overview of SVMC measures for the lower extremity and the evaluation of the level of evidence of the psychometric properties of SVMC measures for children with UMN lesion will be useful for clinicians and researchers planning future studies on the trainability of SVMC.
METHOD Search strategy
To identify studies assessing the psychometric properties of outcome measures of SVMC in children with an UMN lesion the following databases were searched without any time limit until July 2016: MEDLINE, Embase, CINAHL, PsycINFO, Scopus, Cochrane, and PEDro. The search strategy included keywords and synonyms for SVMC, as well as names of tools previously used to measure SVMC, the population of interest, and a validated search filter for finding studies on measurement properties. 22 An example of the search strategy used for MED-LINE is included in Appendix S1 (online supporting information). In addition, to identify additional studies, we hand-searched the reference lists of the articles included in the review.
Study selection
We used a previously developed proprietary database (Microsoft Access 2010; Microsoft Corp., Redmond, WA, USA) to enter the data systematically and score the methodological quality of the studies. 23 Inclusion and exclusion criteria were defined in advance. In accordance to the definition of SVMC, stated above, only papers dealing with selective movement of one joint of the lower extremity or with a primary selective (not synergistic) voluntary multijoint movement were included. For example, papers dealing with the ankle dorsiflexion during initial contact or investigating pathological synergy patterns during walking (i.e. activation of the rectus femoris and semitendinosus muscles during swing phase) were included, whereas papers measuring SVMC over the whole gait cycle or during gross motor coordination tasks were excluded. Considering that SVMC comprehends how accurately and smoothly someone can isolate the selection of a particular muscle group, papers describing the measurement of submaximal torque steadiness were included (i.e. ICF body function level b7300 power of isolated muscle activation). However, studies on maximal voluntary contraction were excluded, as patients with impaired SVMC tend to produce maximal force by using mass synergy patterns. 24, 25 Furthermore, neuroimaging measures, testing structural and metabolic intactness of the involved underlying neurophysiological structures, or networks involved in SVMC (i.e. ICF body structure levels 1100, corticospinal tract, primary cortex) were excluded. Only papers dealing with children and young people (3-21y) with UMN lesions were included. This age range was chosen for neurophysiological reasons (e.g. maturation of the corticospinal tract) and practical reasons (e.g. compliance/understanding). Studies with the explicit aim of assessing one or more psychometric properties were included, as well as cohort studies indirectly investigating the psychometric characteristics of an outcome measure by, for instance, looking at the difference between neurologically intact children and those with UMN lesions. All other forms of indirect evidence (i.e. intervention studies) were excluded. Only articles published in English and German were included for review.
Two reviewers (JB and MLvdL) independently screened all titles and abstracts of the papers. In cases of doubt, the full-text article was consulted to decide whether or not the study met the inclusion criteria. A third reviewer was available if no consensus could be achieved.
Quality evaluation
Evaluation of the methodological quality of the included papers was carried out independently by JB and MLvdL by using the four-point rating scale ('excellent', 'good', 'fair', 'poor', or 'not applicable') of the COnsensus-based Standards for the selection of health Measurement INstruments What this paper adds
• Very few studies evaluate validity and reliability of selective voluntary motor control measures.
• Responsiveness studies of selective voluntary motor control measures are lacking.
• We can currently recommend the Selective Control Assessment of the Lower Extremity measure/tool.
• The evidence level of objective interval-scaled selective voluntary motor control measures is limited.
(COSMIN) checklist. 26 The COSMIN checklist consists of three domains, namely validity ('The degree to which an [Health-Related Patient-Reported Outcomes (HR-PRO)] instrument measures the construct(s) it purports to measure'), reliability ('The extent to which scores for patients who have not changed are the same for repeated measurement under several conditions'), and responsiveness ('The ability of an [HR-PRO] instrument to detect change over time in the construct to be measured'). 26 Each domain contains one or more measurement properties. The reviewer selects the measurement properties (COSMIN boxes) evaluated in the study and scores the specific item lists via the aforementioned ordinal scoring system. The lowest score of all items of the chosen COSMIN box determines the overall methodological quality of the paper. In line with previous COSMIN reviews in the field of neuropaediatrics, we adopted the overall COSMIN score by omitting the item regarding sample size. 21, 23 To ensure that both raters scored the papers in accordance to the guidelines and to allow other raters to arrive at the same conclusion, the following procedures were established prior to the independent COSMIN rating: raters were familiarized with the COSMIN manual and terminology, and discussed the scoring of two papers and established additional rating rules (Appendix S2, online supporting information). Although the COSMIN manual provides general rules for all boxes and items, for some items the COSMIN rating is still open to subjective interpretation, for example 'time interval appropriate'. It is for this reason that COSMIN itself recommends specification of additional rules for individual reviews. 27 If the two reviewers could not agree on a score, a third reviewer was made available.
For the assessment of quality of the measurement properties, the updated criteria suggested by Terwee et al. 28 were applied (Appendix S3, online supporting information). The overall level of evidence for each SVMC measure and each measurement property was evaluated according to the Cochrane Back Review Group Criteria: 29 'strong', 'moderate', 'limited', 'conflicting', 'unknown' (Appendix S4, online supporting information). This overall score was given in relation to the methodological quality of the study and the results of the measurement properties. 26 Again, criteria for sample size were adapted as follows: sample sizes greater than 100 participants of the combined studies were rated as 'strong' (+++ or ---); studies with a sample size between 50 and 99 were rated as 'moderate' (++ or --); studies with a sample size between 25 and 59 as 'limited' (+ or -); and sample size less than 25 as 'unknown' (?). 30 
RESULTS

Description of the included studies
The systematic search resulted in 3590 references being identified. Based on the titles and abstracts, 33 papers were included for full-text reading. After applying the inclusion and exclusion criteria, 17 papers were retained for review ( Figure S1 , online supporting information). The following psychometric properties were evaluated: hypotheses testing/construct validity was assessed in 17 studies, reliability in six (interrater, n=5; test-retest, n=3; intrarater, n=1), and both content and criterion validity in one study. Responsiveness was not evaluated in any study. Most studies tested the SCALE (n=9), followed by studies evaluating torque steadiness measures (n=2), kinematic measures (n=4), and EMG of selected lower limb muscles (n=1). The age of the participants in the studies included for final review ranged from 2 to 21 years, with the exception of one study, 31 where the oldest participant was 28 years of age. Although this age range was slightly wider than the one set by the inclusion criteria (3-21y), discussing this issue ended in the common decision for inclusion. As the mean age ranged from 9 years 3 months to 16 years, the youngest and the oldest participant were seen as outliers. Sample size varied from eight to 51 participants. All studies included children with a diagnosis of CP. In two cohort studies data of children with CP who had undergone a selective dorsal rhizotomy were compared with those of a control group children with CP who had not. 32, 33 Selective dorsal rhizotomy is a neurosurgical procedure, which aims to minimize the limiting influence of spasticity on motor control in children with spastic CP. The comparison of SVMC between children with and without rhizotomy was therefore considered an assessment of the validity of the SVMC tool. Four other cohort studies investigated the construct validity of the SVMC instrument, 31, [34] [35] [36] by comparing patients with CP with participants who were neurologically intact. General characteristics and clinical utility for each SVMC measure is summarized in Table SI (online supporting information) . The methodological quality per measurement property, as well as the overall evidence criteria, can be seen in Table SII (online supporting information).
Hypotheses testing
Of the 17 papers that evaluated construct validity ('hypotheses testing'), 10 papers included clinical assessment tools and seven papers laboratory-based measurement tools (Tables SI and SII) .
Nine of the 10 papers regarding clinical assessment tools evaluated construct validity of the SCALE. The modified COSMIN scores of three of these eight SCALE papers were 'good', [37] [38] [39] four were rated as 'fair', [40] [41] [42] one as 'excellent', 43 and one as 'poor'. 44 Quality of construct validity was evaluated in accordance to Terwee et al. 28 as 'positive (+)' in eight papers, [37] [38] [39] [40] [41] [42] 45 and as mixed 'positive/negative (+)/(-)' in one study. 44 Overall, there was 'moderate positive (++)' evidence for construct validity of the SCALE in terms of (1) its correlation with the Gross Motor Function Classification System, 37,43 and (2) its proximal-distal concordance (SVMC is more often and/or more severely impaired in distal body parts). 38, 43 A 'limited positive (+)' evidence level was given for its validity testing with the Berg Balance Scale, 45 and for predicting knee flexion during initial contact during stance phase of gait. 42 Three studies investigated relationships between total limb SCALE scores and knee flexion during swing phase. Two studies found significant correlations and one did not. [39] [40] [41] Therefore, their level of evidence was rated as 'conflicting (AE)'. In relation to the poor quality of the Kusumoto et al. study, 44 which investigated the relationship between the SCALE and knee extensor strength, its level of evidence was rated as 'unknown (?)'. Therefore, this study did not contribute to the overall evidence level of the SCALE.
In the other three SVMC clinical assessment tools construct validity was only evaluated for the Gillette's SMC test. The study of Manikowska et al. compared, using EMG, Gillette's knee flexion SMC scores in patients with CP versus participants who were neurologically intact. 31 This study received a 'poor' modified COSMIN score, but results were rated as 'positive (+)' in accordance to Terwee et al. 28 The level of evidence was evaluated as 'unknown (?)'. 30 Seven papers investigated construct validity of SVMC using laboratory-based measurement tools, including lower limb kinematics, 32, 34, 39, 40 EMG, 33 and torque steadiness. 35, 36 Two kinematic papers were already evaluated in relation to the SCALE's construct validity (see previous paragraph), 39 ,40 but we decided to list them under this section as well. As there is no criterion standard measure for quantifying SVMC, and the papers are cohort studies investigating the correlation between the SCALE and a kinematic measure for SVMC, they could be regarded not only as studies investigating the construct validity of the SCALE, but also of the kinematic measures, depending on which measure is regarded as more 'established'. As the quality and evidence rating of the two studies is the same as presented above, 39 ,40 the results will not be repeated here. Their COSMIN methodological quality was rated as 'fair' and quality of construct validity was rated as 'positive (+)' in three studies, [34] [35] [36] and as mixed 'positive/negative (+)/(-)' in two. 32, 33 Because the sample size was too small (n<25) in three studies, the evidence level was only scored for one kinematic and one EMG study. 33, 34 Because the results of these studies were ambiguous in supporting the construct validity of the SVMC measurement method, a 'conflicting (AE)' evidence rating was assigned.
Overall, the methodological quality of the majority of the abovementioned studies was reduced owing to the absence of a priori formulated hypotheses, thereby limiting their COSMIN, 27 as well as validity, quality scoring. 29 
Content and criterion validity
Content and criterion validity were only assessed for the SCALE (Table SII) . 37, 43 COSMIN rating of content validity was considered 'poor'. 27 Although 14 experts were involved on item agreement for statements about content, administration, and grading of the SCALE, the paper lacked a description of whether all items were relevant for the construct or for the population of interest. 37 The quality rating of the results was scored as 'indeterminate (?)' and the evidence as 'unknown (?)'. 27 The method applied to establish criterion validity of the SCALE was rated as 'excellent'. 43 As the Fugl-Meyer Assessment (items III and IV) measures a similar construct as the SCALE and correlation exceeded 0.70, the SCALE criterion validity results were rated as 'positive (+)'. Therefore, a 'limited positive (+)' evidence level was given for criterion validity of the SCALE.
Reliability
Reliability was investigated in three (SMC, mTrost, SCALE) 37, 43, 46, 47 of the four clinical assessment tools and in two (kinematic, torque) 32, 35 of five laboratory-based SVMC tools. The SMC test-retest reliability was tested in two studies. 46, 47 The modified COSMIN rating for SMC interrater reliability ranged from 'fair' to 'good'. 27, 46, 47 The methodological quality of interrater reliability of the mTrost test was also rated 'fair'. 47 Interrater reliability of the SCALE was tested by two studies and scored as 'excellent' and 'good'. 37, 43 The SCALE's intrarater reliability was further investigated and received a 'good' modified COSMIN score. 43 The methodological quality of test-retest reliability for the kinematic and torque steadiness measure was evaluated as 'good'. 32, 35 Overall, studies assessing interrater reliability were rated lowest for COSMIN items describing the statistical procedures (i.e. description of weighted scheme intraclass correlation coefficient, kappa). The items regarding the stability of participants between the two or more assessments and the description of test conditions were the most limiting items for the four studies on test-retest and intrarater reliability.
Applying the quality criteria for measurement properties revealed 'positive (+)' results for four reliability studies; 32, 37, 43, 46 mixed 'positive/negative (+)/(-)' results in three studies; 35, 46, 47 and 'negative (-)' results for interrater reliability of the SMC test. 29 When evaluating the overall evidence level using Cochrane guidelines, 30 we found 'moderate positive results (++)' for the inter-and intrarater reliability of the SCALE. 37, 43 'Moderate negative results (--)' were evident for the interrater reliability of the SMC, 46, 47 and 'limited negative results (-)' for the mTrost. 47 Owing to the low sample size (n<25) the evidence level of the test-retest reliability of the kinematic and torque steadiness measurement studies was scored as 'unknown (?)'.
32,35
DISCUSSION
This review revealed a limited number of psychometric studies investigating SVMC measures in children with UMN lesions. The overall evidence was further limited as 10 out of 17 studies were cohort studies with a limited methodological quality (i.e. 'poor' or 'fair'), with the exception of one study, 39 which was scored 'good' according to modified COSMIN rating guidelines. No study investigated responsiveness, which we consider a crucially important measurement property, especially in the context of the ongoing debate about trainability of SVMC. Although we explicitly searched for the whole population of paediatric UMN lesions, only psychometric studies including children with CP were found. Therefore, the results of this review are limited to children with CP and cannot be directly transferred to other children with impaired SVMC (i.e. acquired brain injuries). The chosen age range (3-21y) for this review, might have been wide when considering developmental issues known to influence SVMC (e.g. maturation of central nervous system function), as well as the importance of the participants' cognitive understanding and motivation for the SVMC measurement procedure/testing. Nevertheless, this age range was chosen owing to the overall limited number of studies available for review. Future studies regarding SVMC measures may choose to investigate psychometric properties in separate age groups (i.e. pre-central nervous system maturation 2-7y, and post-central nervous system maturation <8y).
The SCALE was the most often investigated assessment tool, in terms of number of studies conducted and in the number of measurement properties investigated. The SMC and mTrost were only rated on reliability, thus lacking evidence on their validity. The Gillette's SMC test was only investigated on its validity, lacking evidence about its reliability. In terms of psychometric quality, the SCALE had the highest level of evidence with a moderate positive level of evidence concerning its interrater reliability and its construct validity, and an unknown and limited level of evidence of content and criterion validity respectively. Another advantage of the SCALE over the other assessment tools (SMC, mTrost) lies in its evaluation of five lower extremity joints rather than one or three joints. In addition, clinical utility (Table SI) of the SCALE, as well as of the other SMC assessment tools, was scored high as required time, costs, and resources are low. However, in terms of limitations, the SCALE's application is limited to children with spastic CP. Furthermore, as its ordinal scoring system relies on the impression of the rater (i.e. therapist, consultant), it is a subjective measurement. Finally, the SCALE's three-level ordinal scoring system (normal, impaired, and unable) may lack sensitivity to detect certain therapy-induced changes of SVMC. These limitations (spastic CP, ordinal scoring system) also apply for the other three clinical tools.
The construct validity of the kinematic, EMG, and torque steadiness was assessed, but none of the papers evaluating these measurement techniques explicitly mentioned that the assessment of validity was an a priori objective. Because of this, the formulation of hypotheses was often absent thus diminishing their modified COSMIN score to 'fair'. Only two laboratory-based SVMC measures (kinematic, torque steadiness) 32, 35 were assessed regarding their test-retest reliability. In terms of psychometric quality, as well as clinical utility (Table SI) , none of the identified laboratory-based measures seem to offer great advantage over the other. The equipment required to record the outcome measures was often customized, making it difficult for other groups (researchers or clinicians) to apply and confirm or extend findings of studies exploring the laboratory-based measures using EMG, kinematics, or torque measurements. Furthermore, the measurement procedures appear time-consuming and complex in comparison with more routinely applied clinical assessments. Personnel also required extensive training in the application and analysis of these measures (Table SI) . In summary, the results from this systematic review show the limited level of evidence regarding the psychometric properties (reliability and validity) and absence of evidence regarding responsiveness of currently available SVMC measures of the lower extremity in children with UMN lesions.
Methodological considerations
Low interrater agreement when rating the quality of the evidence in systematic reviews (e.g. rating risk of bias in Cochrane type reviews) can be an important methodological issue, which should be considered when conducting a systematic review. 48 Herein, agreement between the raters for all COSMIN items was high. Only five out of 246 items needed further discussion, and none required the rating of a third reviewer. This high agreement was likely the result of the specific rating rules which we established as recommended by the COSMIN group. For example, when scoring the reliability items 4 to 7 for the SCALE, we decided in advance to score the use of video for the evaluating of the inter-and intrarater reliability as appropriate, as this allows a discrete evaluation of the scoring system by maintaining the stability of test conditions and patient status, as well as saving on time and resources. In contrast, a video approach was not considered to be appropriate for determining test-retest reliability when the stability of the patient is evaluated.
In line with other neuropaediatric COSMIN reviews, 22, 24, 49 we modified the rating of the sample size item (modified COSMIN score) as the sample size is often limited in clinical neuropaediatric studies and not comparable with large-scale epidemiological healthcare studies using patient-reported outcome measures for which the COSMIN guidelines were initially evaluated. This modified scoring improved the overall rating of all studies with the exception of the construct and content validity score of the studies from Zwaan et al. 33 and Fowler et al. 37 Although we used this modified score, we recommend that future psychometric studies should include a sufficiently large sample size (>30).
Other reasons for scoring poor were the lack of 'a priori' formulated hypotheses (box 'hypothesis testing'), and for one study the lack of evaluating each item separately for its content validity (box 'content validity'). 37 While we consider it important that each single question should be evaluated separately for its content validity in a healthcare questionnaire (which the COSMIN was originally developed for), it could be questioned whether the same rating rules are needed for an assessment tool like the SCALE that consists of a similar procedure repeated for different joints.
Future research directions
The results of this review show that the SCALE is the most frequently investigated assessment method in the population of children with CP and also has the highest quality rating. Its responsiveness to change has not been assessed, but it may be expected that owing to its ordinal scoring system its sensitivity to measure changes of SVMC is limited. To improve its sensitivity and, simultaneously, to benefit from its child-friendly procedure, combining the SCALE with another, more sensitive measure appears to be promising. This idea has also been proposed in previous studies. 33, 50 While Zwaan et al. found no convincing evidence for detecting extensor and flexor synergies during gait using EMG in children with CP, 33 they reported a significant cross-correlation between extensor synergy activity measured using EMG and the mTrost test. They concluded that 'EMG measures still may be useful for selective motor control measurement because it measures selectivity at the level of the specific muscles involved, provided the appropriate task is used'. 33 As walking requires selective, as well as synergistic movements, we considered it not to be an appropriate task for the assessment of SVMC. The tasks embedded in the SCALE (isolated single-joint movements) were developed in accordance with the definition of SVMC. 8, 37 Combining SCALE's ratings for single-joint movements with EMG recordings would further allow for directly measuring voluntary activation of a muscle, even in patients with low muscle strength (manual muscle test grade of 1), where no real joint movement occurs.
CONCLUSION
This systematic review revealed a limited number of psychometric studies evaluating the validity and reliability of SVMC measures in children with UMN lesions, and no studies evaluating responsiveness. Currently, the SCALE appeared to have the highest level of evidence regarding its reliability and construct validity compared with other clinical and laboratory-based measures of SVMC. However, only by means of reliable, validated, and responsive SVMC tools used in carefully designed intervention studies, will it be possible to provide a scientifically rigorous contribution to the ongoing debate with regard to the possibility to improve SVMC of the lower extremity in children with UMN lesions. the Zurich Center for Neuroscience. None of the funders were involved in the study design, data collection, analysis, and manuscript preparation and publication decisions. All ideas and decisions in relation to this study were made independently by the authors. The authors have stated that they had no interests which might be perceived as posing a conflict or bias.
SUPPORTING INFORMATION
The following additional material may be found online:
Appendix S1: Search construct: psychometric studies of selective voluntary motor control measures for the lower extremity in children with upper motor neuron lesions.
Appendix S2: Specified COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) rating rules.
Appendix S3: Quality criteria for measurement properties. Appendix S4: Levels of evidence for the overall quality of the measurement properties (based on the Cochrane Back Review Group 2003). Figure S1 : Selection process systematic review. SVMC, selective voluntary motor control. 
